{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T04:02:43Z","timestamp":1745208163778,"version":"3.40.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,19]]},"DOI":"10.7759\/cureus.82602","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T03:19:51Z","timestamp":1745119191000},"source":"Crossref","is-referenced-by-count":0,"title":["Heart Failure With Preserved Ejection Fraction and Low B-type Natriuretic Peptide: A Diagnostic Dilemma"],"prefix":"10.7759","author":[{"given":"Tyler","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin Ur Rehman","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed M","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled A","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, et al.. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021, 10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield MM","year":"2016","unstructured":"Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med. 2016, 375:1868-77. 10.1056\/NEJMcp1511175","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske B","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, et al.. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019, 40:3297-317. 10.1093\/eurheartj\/ehz641","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112629","article-title":"Natriuretic peptides in heart failure with preserved left ventricular ejection fraction: from molecular evidences to clinical implications","volume":"20","author":"Tanase DM","year":"2019","unstructured":"Tanase DM, Radu S, Al Shurbaji S, et al.. Natriuretic peptides in heart failure with preserved left ventricular ejection fraction: from molecular evidences to clinical implications. Int J Mol Sci. 2019, 20:10.3390\/ijms20112629","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2894","article-title":"Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension","volume":"25","author":"Anker SD","year":"2023","unstructured":"Anker SD, Usman MS, Anker MS, et al.. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur J Heart Fail. 2023, 25:936-55. 10.1002\/ejhf.2894","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022, 79:e263-421. 10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7229.236","article-title":"ABC of heart failure. Clinical features and complications","volume":"320","author":"Watson RD","year":"2000","unstructured":"Watson RD, Gibbs CR, Lip GY. ABC of heart failure. Clinical features and complications. BMJ. 2000, 320:236-9. 10.1136\/bmj.320.7229.236","journal-title":"BMJ"},{"key":"ref8","article-title":"The role of BNP testing in heart failure","volume":"74","author":"Doust J","year":"2006","unstructured":"Doust J, Lehman R, Glasziou P. The role of BNP testing in heart failure. Am Fam Physician. 2006, 74:1893-8.","journal-title":"Am Fam Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.04.027","article-title":"Low natriuretic peptide levels and outcomes in patients with heart\u00a0failure and preserved ejection fraction","volume":"12","author":"Kondo T","year":"2024","unstructured":"Kondo T, Campbell R, Jhund PS, et al.. Low natriuretic peptide levels and outcomes in patients with heart\u00a0failure and preserved ejection fraction. JACC Heart Fail. 2024, 12:1442-55. 10.1016\/j.jchf.2024.04.027","journal-title":"JACC Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0601-z","article-title":"NTproBNP in insulin-resistance mediated conditions: overweight\/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study","volume":"16","author":"Baldassarre S","year":"2017","unstructured":"Baldassarre S, Fragapani S, Panero A, et al.. NTproBNP in insulin-resistance mediated conditions: overweight\/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study. Cardiovasc Diabetol. 2017, 16:119. 10.1186\/s12933-017-0601-z","journal-title":"Cardiovasc Diabetol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.02.008","article-title":"Racial differences in natriuretic peptide levels: the Dallas Heart Study","volume":"3","author":"Gupta DK","year":"2015","unstructured":"Gupta DK, de Lemos JA, Ayers CR, Berry JD, Wang TJ. Racial differences in natriuretic peptide levels: the Dallas Heart Study. JACC Heart Fail. 2015, 3:513-9. 10.1016\/j.jchf.2015.02.008","journal-title":"JACC Heart Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.05.049","article-title":"Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP","volume":"60","author":"Macheret F","year":"2012","unstructured":"Macheret F, Heublein D, Costello-Boerrigter LC, et al.. Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. J Am Coll Cardiol. 2012, 60:1558-65. 10.1016\/j.jacc.2012.05.049","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2018.09.031","article-title":"ACR Appropriateness Criteria(\u00ae) suspected new-onset and known nonacute heart failure","volume":"15","author":"White RD","year":"2018","unstructured":"White RD, Kirsch J, Bolen MA, et al.. ACR Appropriateness Criteria(\u00ae) suspected new-onset and known nonacute heart failure. J Am Coll Radiol. 2018, 15:S418-31. 10.1016\/j.jacr.2018.09.031","journal-title":"J Am Coll Radiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2021.34","article-title":"Contemporary review of hemodynamic monitoring in the critical care setting","volume":"16","author":"Rali AS","year":"2022","unstructured":"Rali AS, Butcher A, Tedford RJ, Sinha SS, Mekki P, Van Spall HG, Sauer AJ. Contemporary review of hemodynamic monitoring in the critical care setting. US Cardiol. 2022, 16:e12. 10.15420\/usc.2021.34","journal-title":"US Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/349410-heart-failure-with-preserved-ejection-fraction-and-low-b-type-natriuretic-peptide-a-diagnostic-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T03:19:52Z","timestamp":1745119192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/349410-heart-failure-with-preserved-ejection-fraction-and-low-b-type-natriuretic-peptide-a-diagnostic-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.82602","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,19]]}}}